PaxMedica, Inc. Common Stock
PXMD · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $2 | $2 | $1 |
| G&A Expenses | $12,230 | $9 | $5 | $5 |
| SG&A Expenses | $12 | $9 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $16 | $11 | $7 | $6 |
| Operating Income | -$16 | -$11 | -$7 | -$6 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$4 | -$3 | -$2 |
| Pre-Tax Income | -$18 | -$15 | -$10 | -$8 |
| Tax Expense | $0 | $4 | $3 | $1 |
| Net Income | -$18 | -$15 | -$13 | -$8 |
| % Margin | – | – | – | – |
| EPS | -11 | -28.73 | -18.81 | -13.42 |
| % Growth | 61.7% | -52.7% | -40.2% | – |
| EPS Diluted | -11 | -28.73 | -18.81 | -13.42 |
| Weighted Avg Shares Out | 2 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 2 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $3 | $1 |
| Depreciation & Amortization | $2 | $0 | $0 | $0 |
| EBITDA | -$16 | -$17 | -$7 | -$6 |
| % Margin | – | – | – | – |